FindTrial
Sign In

A real world study for Benvitimod cream in the treatment of lichen simplex chronicus

A real world study for Benvitimod cream in the treatment of lichen simplex chronicus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056779
Enrollment
Unknown
Registered
2022-02-16
Start date
2022-02-17
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lichen simplex chronicus

Interventions

NA:Benvitimod cream

Sponsors

Hainan Meixin Internet hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The age is more than 18 years old; 2. Judging by the researchers, the application of cream in the treatment of patients with lichen simplex chronicus ; 3. TSS=8,and Target lesions Mossification score=2,pruritus score=2; 4. Women who are not pregnant and do not plan to become pregnant during the trial; 5. Fully understands the test content, voluntary testing, has signed a consent form; 6. Volunteer to participate in this observational study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy, breastfeeding women, or by women during pregnancy; 2. known to be allergic to the research activity of drug components or accessories; 3. you may be other reasons to complete the study in patients with, or researchers do not consider it appropriate to this researcher.

Design outcomes

Primary

MeasureTime frame
TSS;—

Contacts

Public ContactZhu Wei
Xinmin.zhang@meditrusthealth.com13524058309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026